Scribe Therapeutics Closes Series B Round With $100M To Target Gene Editing
Crunchbase News
|
March 31, 2021
X min read
Crunchbase News
|
March 31, 2021
Share on Social
More like this
Media
Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
September 2, 2026
Read Now
Press
Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
September 2, 2026
Read Now
